SCHEMBL22988863

SCHEMBL22988863

Cc1nc(NC(=O)N2CCC(C)(C)C2=O)ccc1Cc1c[nH]c2ncc(Cl)cc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KIT P10721 5/20 0.45
▸ CSF1R P07333 4/20 0.45
▸ PDGFRA P16234 4/20 0.45
▸ CYP3A4 P08684 10/20 0.44
▸ CYP1A2 P05177 2/20 0.44
▸ CYP2C9 P11712 2/20 0.42
▸ CYP2C19 P33261 4/20 0.41
▸ CYP2D6 P10635 1/20 0.40
▸ KDR P35968 2/20 0.39
▸ FLT3 P36888 2/20 0.39
▸ LCK P06239 1/20 0.39
▸ PGR P06401 1/20 0.39
▸ CHRM2 P08172 1/20 0.39
▸ HTR1A P08908 1/20 0.39
▸ ADRA2A P08913 1/20 0.39
▸ PDGFRB P09619 1/20 0.39
▸ ADORA3 P0DMS8 1/20 0.39
▸ CHRM1 P11229 1/20 0.39
▸ FLT1 P17948 1/20 0.39
▸ DRD1 P21728 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22988876 0.89 CSF1R (0.46) KITCSF1RPDGFRACYP3A4CYP1A2
SCHEMBL22988865 0.89 CSF1R (0.45) KITCSF1RPDGFRACYP3A4CYP1A2
SCHEMBL22988862 0.87 CSF1R (0.44) KITCSF1RPDGFRACYP3A4CYP1A2
SCHEMBL22988846 0.86 CSF1R (0.45) KITCSF1RPDGFRACYP3A4CYP2C9
SCHEMBL22988864 0.84 CSF1R (0.41) KITCSF1RPDGFRACYP3A4CYP1A2
SCHEMBL22978560 0.75 GPR84 (0.41) KITCSF1RPDGFRACYP3A4CYP2C19
SCHEMBL27117863 0.73 CSF1R (0.45) KITCSF1RPDGFRAKDRPDGFRB
SCHEMBL21873012 0.72 CYP3A4 (0.53) KITCSF1RPDGFRACYP3A4CYP1A2
SCHEMBL21425521 0.71 CSF1R (0.71) KITCSF1RPDGFRAPDGFRB
SCHEMBL22988825 0.71 CSF1R (0.44) KITCSF1RPDGFRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018233526-A9 CSF1R INHIBITOR, AND MANUFACTURING METHOD THEREFOR AND APPLICATION THEREOF 上海和誉生物医药科技有限公司 2021-02-18 — — WO disclosed
US-20160340361-A1 PIPERIDINE INHIBITORS OF JANUS KINASE 3 AUSPEX PHARMACEUTICALS, INC. 2016-11-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160340361-A1 PIPERIDINE INHIBITORS OF JANUS KINASE 3 JAK2, JAK3, PAK3 KIT 360/4885CSF1R 1210/4885PDGFRA 147/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback